Biomarker Applications for Improved Clinical Trial Outcomes 2011 November 14, 2011

Biomarker Applications for Improved Clinical Trial Outcomes 2011 highlights the use of biomarkers and diagnostics during every stage of clinical research, to stratify patients, prove clinical validity, and streamline the regulatory approval and reimbursement process. The event aims to advise on how to fully integrate drug pipeline diagnostic needs with trial design methods.

Brandon Higgs will present “Biomarkers that facilitate clinical trials for autoimmune disease research.”